Lara H E, McDonald J K, Ahmed C E, Ojeda S R
Division of Neuroscience, Oregon Regional Primate Research Center, Beaverton 97006.
Endocrinology. 1990 Nov;127(5):2199-209. doi: 10.1210/endo-127-5-2199.
Immunosympathectomy produced by treatment of newborn rats with antibodies to nerve growth factor (NGF) delays ovarian development and disrupts estrous cyclicity. While these alterations have been ascribed to loss of sympathetic neurons innervating the ovary, the treatment also causes partial loss of ovarian sensory innervation. The present experiments were undertaken to determine if selective interference with ovarian noradrenergic/sympathetic action would result in alterations of ovarian development similar to those caused by NGF antibodies (NGF Ab). We have used two approaches to disrupt catecholamine action on ovarian cells: 1) inhibition of beta-adrenoreceptors by local delivery of receptor blockers to the ovaries of juvenile rats; and 2) elimination of the sympathetic innervation by long term postnatal treatment with guanethidine (GD), an adrenergic neuron blocking agent. When GD is administered chronically it produces an autoimmune-mediated destruction of peripheral sympathetic nerves, without affecting cholinergic or sensory neurons. Of the receptor blockers tested, FM-24, a nonreversible antagonist, resulted in a sustained 70% decrease in available receptors throughout the 10-day period studied. In spite of this, the timing of puberty, assessed by the age at vaginal opening and first ovulation, was not delayed, suggesting that activation of the remaining receptors by an intact innervation suffices to maintain a normal noradrenergic influence. GD treatment initiated at the end of the first week of postnatal life and maintained for three weeks slowed the juvenile-peripubertal rate of body growth, delayed the time of vaginal opening and first ovulation, and disrupted subsequent estrous cyclicity, but did not affect the animals' fertility. The ovaries of GD-treated rats exhibited a striking loss of sympathetic (norepinephrine and neuropeptide Y) nerves but a normal sensory innervation (represented by fibers containing calcitonin gene-related peptide). The concentration of beta-adrenoreceptors in granulosa cells was reduced, suggesting follicular immaturity. Direct assessment of this inference by morphometric analysis of the ovaries revealed that follicular development was retarded. The progesterone and estrogen response of juvenile ovaries to gonadotropins in vitro were also reduced. At this time, circulating LH levels were slightly decreased, but neither LHRH content in the median eminence nor the LHRH response to prostaglandin E2 in vitro were affected.(ABSTRACT TRUNCATED AT 400 WORDS)
用抗神经生长因子(NGF)抗体处理新生大鼠所产生的免疫交感神经切除术会延迟卵巢发育并扰乱发情周期。虽然这些改变被归因于支配卵巢的交感神经元的丧失,但该处理也会导致卵巢感觉神经支配的部分丧失。进行本实验以确定选择性干扰卵巢去甲肾上腺素能/交感神经作用是否会导致类似于NGF抗体(NGF Ab)所引起的卵巢发育改变。我们采用了两种方法来破坏儿茶酚胺对卵巢细胞的作用:1)通过将受体阻滞剂局部递送至幼鼠卵巢来抑制β-肾上腺素能受体;2)用胍乙啶(GD)进行长期产后处理以消除交感神经支配,胍乙啶是一种肾上腺素能神经元阻断剂。当长期给予GD时,它会产生自身免疫介导的外周交感神经破坏,而不影响胆碱能或感觉神经元。在所测试的受体阻滞剂中,不可逆拮抗剂FM - 24在整个研究的10天期间使可用受体持续减少70%。尽管如此,通过阴道开口年龄和首次排卵年龄评估的青春期时间并未延迟,这表明完整的神经支配对剩余受体的激活足以维持正常的去甲肾上腺素能影响。产后第一周结束时开始并持续三周的GD处理减缓了幼年期至青春期前的身体生长速度,延迟了阴道开口和首次排卵的时间,并扰乱了随后的发情周期,但不影响动物的生育能力。接受GD处理的大鼠卵巢表现出交感神经(去甲肾上腺素和神经肽Y)神经的显著丧失,但感觉神经支配正常(以含有降钙素基因相关肽的纤维为代表)。颗粒细胞中β-肾上腺素能受体的浓度降低,表明卵泡不成熟。通过对卵巢进行形态计量分析直接评估这一推断发现卵泡发育受阻。幼鼠卵巢在体外对促性腺激素的孕酮和雌激素反应也降低。此时,循环中的促黄体生成素(LH)水平略有下降,但正中隆起中的促性腺激素释放激素(LHRH)含量以及体外LHRH对前列腺素E2的反应均未受到影响。(摘要截短至400字)